IGFBP-2 partly mediates the early metabolic improvements caused by bariatric surgery

[1]  A. Bellizzi,et al.  Endocannabinoid Receptor-1 and Sympathetic Nervous System Mediate the Beneficial Metabolic Effects of Gastric Bypass , 2020, Cell reports.

[2]  Shumsuzzaman Khan.  IGFBP-2 Signaling in the Brain: From Brain Development to Higher Order Brain Functions , 2019, Front. Endocrinol..

[3]  Mohit M. Jain,et al.  Biliopancreatic Diversion Induces Greater Metabolic Improvement Than Roux-en-Y Gastric Bypass. , 2019, Cell metabolism.

[4]  H. Berthoud,et al.  Combined loss of GLP-1R and Y2R does not alter progression of high-fat diet-induced obesity or response to RYGB surgery in mice , 2019, Molecular metabolism.

[5]  N. Abumrad,et al.  Metabolic Effects of Bile Acids: Potential Role in Bariatric Surgery , 2019, Cellular and molecular gastroenterology and hepatology.

[6]  F. Santini,et al.  Serum IGF-binding protein 2 (IGFBP-2) concentrations change early after gastric bypass bariatric surgery revealing a possible marker of leptin sensitivity in obese subjects , 2019, Endocrine.

[7]  J. Antoun,et al.  Role of Bile Acids and GLP-1 in Mediating the Metabolic Improvements of Bariatric Surgery. , 2019, Gastroenterology.

[8]  H. Berthoud,et al.  The PYY/Y2R-Deficient Mouse Responds Normally to High-Fat Diet and Gastric Bypass Surgery , 2019, Nutrients.

[9]  D. Levy,et al.  Proteins Altered by Surgical Weight Loss Highlight Biomarkers of Insulin Resistance in the Community , 2019, Arteriosclerosis, Thrombosis and Vascular Biology.

[10]  H. Berthoud,et al.  Roux-en-Y Gastric Bypass Surgery-Induced Weight Loss and Metabolic Improvements Are Similar in TGR5-Deficient and Wildtype Mice , 2018, Obesity Surgery.

[11]  A. Pfeiffer,et al.  Insulin-Like Growth Factor (IGF) Binding Protein-2, Independently of IGF-1, Induces GLUT-4 Translocation and Glucose Uptake in 3T3-L1 Adipocytes , 2017, Oxidative medicine and cellular longevity.

[12]  Gretchen A. Stevens,et al.  Worldwide trends in body-mass index, underweight, overweight, and obesity from 1975 to 2016: a pooled analysis of 2416 population-based measurement studies in 128·9 million children, adolescents, and adults , 2017, Lancet.

[13]  A. Carpentier,et al.  Fatty Acid Metabolic Remodeling During Type 2 Diabetes Remission After Bariatric Surgery , 2017, Diabetes.

[14]  F. Villarroya,et al.  FGF19 and FGF21 serum concentrations in human obesity and type 2 diabetes behave differently after diet- or surgically-induced weight loss. , 2017, Clinical nutrition.

[15]  H. Berthoud,et al.  RYGB Produces more Sustained Body Weight Loss and Improvement of Glycemic Control Compared with VSG in the Diet-Induced Obese Mouse Model , 2017, Obesity Surgery.

[16]  Luis A Tellez,et al.  Gastric Bypass Surgery Recruits a Gut PPAR-α-Striatal D1R Pathway to Reduce Fat Appetite in Obese Rats. , 2017, Cell metabolism.

[17]  S. Bangalore,et al.  Changes in Lipid Profile of Obese Patients Following Contemporary Bariatric Surgery: A Meta-Analysis. , 2016, The American journal of medicine.

[18]  H. Berthoud,et al.  Roux-en-Y gastric bypass surgery is effective in fibroblast growth factor-21 deficient mice , 2016, Molecular metabolism.

[19]  S. Ikramuddin,et al.  FGF 19 and Bile Acids Increase Following Roux-en-Y Gastric Bypass but Not After Medical Management in Patients with Type 2 Diabetes , 2016, Obesity Surgery.

[20]  P. Rorsman,et al.  PYY-Dependent Restoration of Impaired Insulin and Glucagon Secretion in Type 2 Diabetes following Roux-En-Y Gastric Bypass Surgery , 2016, Cell reports.

[21]  S. Koo,et al.  Metformin stimulates IGFBP-2 gene expression through PPARalpha in diabetic states , 2016, Scientific Reports.

[22]  H. Berthoud,et al.  Body Composition, Food Intake, and Energy Expenditure in a Murine Model of Roux-en-Y Gastric Bypass Surgery , 2016, Obesity Surgery.

[23]  A. Hoeflich,et al.  The RGD sequence present in IGFBP-2 is required for reduced glucose clearance after oral glucose administration in female transgenic mice. , 2015, American journal of physiology. Endocrinology and metabolism.

[24]  G. Werther,et al.  IGFBP-2: The dark horse in metabolism and cancer. , 2015, Cytokine & growth factor reviews.

[25]  D. Clemmons,et al.  The Coordinate Cellular Response to Insulin-like Growth Factor-I (IGF-I) and Insulin-like Growth Factor-binding Protein-2 (IGFBP-2) Is Regulated through Vimentin Binding to Receptor Tyrosine Phosphatase β (RPTPβ)* , 2015, The Journal of Biological Chemistry.

[26]  J. Holst,et al.  Improvements in glucose metabolism early after gastric bypass surgery are not explained by increases in total bile acids and fibroblast growth factor 19 concentrations. , 2015, The Journal of clinical endocrinology and metabolism.

[27]  D. Richard,et al.  Metabolic changes induced by the biliopancreatic diversion in diet-induced obesity in male rats: the contributions of sleeve gastrectomy and duodenal switch. , 2015, Endocrinology.

[28]  P. Poirier,et al.  How to choose and use bariatric surgery in 2015. , 2015, The Canadian journal of cardiology.

[29]  J. Després,et al.  Circulating IGFBP-2 levels are incrementally linked to correlates of the metabolic syndrome and independently associated with VLDL triglycerides. , 2014, Atherosclerosis.

[30]  H. Berthoud,et al.  Leptin deficient ob/ob mice and diet-induced obese mice responded differently to Roux-en-Y bypass surgery , 2014, International Journal of Obesity.

[31]  O. Nedić,et al.  Protein molecular forms of insulin-like growth factor binding protein-2 change with aging , 2014, Experimental Gerontology.

[32]  J. Kral,et al.  Biliopancreatic Diversion-Duodenal Switch: Independent Contributions of Sleeve Resection and Duodenal Exclusion , 2014, Obesity Surgery.

[33]  D. Drucker,et al.  Effects of Roux-en-Y gastric bypass on energy and glucose homeostasis are preserved in two mouse models of functional glucagon-like peptide-1 deficiency. , 2014, Molecular metabolism.

[34]  V. Tremaroli,et al.  FXR is a molecular target for the effects of vertical sleeve gastrectomy , 2014, Nature.

[35]  N. Stylopoulos,et al.  GLP-1 receptor signaling is not required for reduced body weight after RYGB in rodents. , 2014, American journal of physiology. Regulatory, integrative and comparative physiology.

[36]  Scott D Covey,et al.  IGFBP2 is neither sufficient nor necessary for the physiological actions of leptin on glucose homeostasis in male ob/ob mice. , 2014, Endocrinology.

[37]  M. Digicaylioglu,et al.  Spatial distribution of insulin-like growth factor binding protein-2 following hypoxic-ischemic injury , 2013, BMC Neuroscience.

[38]  L. Maile,et al.  The heparin-binding domains of IGFBP-2 mediate its inhibitory effect on preadipocyte differentiation and fat development in male mice. , 2013, Endocrinology.

[39]  R. Seeley,et al.  Vertical Sleeve Gastrectomy Is Effective in Two Genetic Mouse Models of Glucagon-Like Peptide 1 Receptor Deficiency , 2013, Diabetes.

[40]  O. Nedić,et al.  Interaction of Insulin-Like Growth Factor-Binding Protein 2 with α2-Macroglobulin in the Circulation , 2013, The Protein Journal.

[41]  P. Puigserver,et al.  Oleic Acid Stimulates Complete Oxidation of Fatty Acids through Protein Kinase A-dependent Activation of SIRT1-PGC1α Complex* , 2013, The Journal of Biological Chemistry.

[42]  H. Berthoud,et al.  Development and Verification of a Mouse Model for Roux-en-Y Gastric Bypass Surgery with a Small Gastric Pouch , 2013, PloS one.

[43]  N. Sonenberg,et al.  Insulin stimulates IGFBP-2 expression in 3T3-L1 adipocytes through the PI3K/mTOR pathway , 2012, Molecular and Cellular Endocrinology.

[44]  P. Poirier,et al.  Upregulation of Plasma Insulin‐Like Growth Factor Binding Protein 2 Levels After Biliopancreatic Diversion in Humans , 2012, Obesity.

[45]  Rennian Wang,et al.  Jejunal nutrient sensing is required for duodenal-jejunal bypass surgery to rapidly lower glucose concentrations in uncontrolled diabetes , 2012, Nature Medicine.

[46]  B. Franklin,et al.  Bariatric surgery and cardiovascular risk factors: a scientific statement from the American Heart Association. , 2011, Circulation.

[47]  F. Picard,et al.  Modulation of IGFBP2 mRNA expression in white adipose tissue upon aging and obesity. , 2010, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

[48]  J. Teixeira,et al.  Superior Appetite Hormone Profile After Equivalent Weight Loss by Gastric Bypass Compared to Gastric Banding , 2010, Obesity.

[49]  P. Schauer,et al.  Bariatric surgery and the gut hormone response. , 2010, Nutrition in clinical practice : official publication of the American Society for Parenteral and Enteral Nutrition.

[50]  R. Wysocki,et al.  Antidiabetic effects of IGFBP2, a leptin-regulated gene. , 2010, Cell metabolism.

[51]  M. Kearney,et al.  IGF-dependent and IGF-independent actions of IGF-binding protein-1 and -2: implications for metabolic homeostasis , 2009, Trends in Endocrinology & Metabolism.

[52]  M. Ranke,et al.  Multidimensional reference regions for IGF-I, IGFBP-2 and IGFBP-3 concentrations in serum of healthy adults. , 2008, Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society.

[53]  J. Teixeira,et al.  Effect of weight loss by gastric bypass surgery versus hypocaloric diet on glucose and incretin levels in patients with type 2 diabetes. , 2008, The Journal of clinical endocrinology and metabolism.

[54]  Antonio Vidal-Puig,et al.  IGF-Binding Protein-2 Protects Against the Development of Obesity and Insulin Resistance , 2007, Diabetes.

[55]  J. Marescaux,et al.  The Mechanism of Diabetes Control After Gastrointestinal Bypass Surgery Reveals a Role of the Proximal Small Intestine in the Pathophysiology of Type 2 Diabetes , 2006, Annals of surgery.

[56]  S. Anderson,et al.  Insulin-like growth factor binding protein-2 (IGFBP-2) is a marker for the metabolic syndrome. , 2006, Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association.

[57]  F. Rubino.  Bariatric surgery: effects on glucose homeostasis , 2006, Current opinion in clinical nutrition and metabolic care.

[58]  A. Alastrué,et al.  Increased Exercise Capacity after Surgically Induced Weight Loss in Morbid Obesity , 2006, Obesity.

[59]  Steve N Caritis,et al.  Elective single-embryo transfer versus double-embryo transfer in in vitro fertilization , 2004, The New England journal of medicine.

[60]  M. Gagner,et al.  Taking Posterior Rectus Sheath Laparoscopically to Reinforce the Gastrojejunostomy in Laparoscopic Roux-en-Y Gastric Bypass , 2003, Obesity surgery.

[61]  M. Vranic,et al.  The effect of systemic versus portal insulin delivery in pancreas transplantation on insulin action and VLDL metabolism. , 2001, Diabetes.

[62]  A. Hoeflich,et al.  Overexpression of Insulin-Like Growth Factor-Binding Protein-2 in Transgenic Mice Reduces Postnatal Body Weight Gain. , 1999, Endocrinology.

[63]  L. Biertho,et al.  Duodenal switch improved standard biliopancreatic diversion: a retrospective study. , 2009, Surgery for obesity and related diseases : official journal of the American Society for Bariatric Surgery.

[64]  A. Hoeflich,et al.  Overexpression of insulin-like growth factor-binding protein-2 in transgenic mice reduces postnatal body weight gain. , 1999, Endocrinology.